People with symptoms indicative of diabetic polyneuropathy near the time of type 2 diabetes diagnosis have a “markedly higher” risk for subsequent cardiovascular disease than those without, researchers report.
Researchers have created and validated a cardiovascular disease risk tool that substantially improves risk prediction in people with type 1 diabetes and indicates that statins may not always be needed in younger members of this group.
Among people with type 2 diabetes, those with hypoglycemic events, microvascular complications, or high or unstable glycated hemoglobin levels might have an increased risk for dementia, researchers report.
Implementation of widespread screening for diabetes “radically” alters the cardiovascular risk profile of people with newly detected diabetes, rendering existing cardiovascular risk prediction tools inaccurate, say researchers.
A closed-loop system with an artificial intelligence component that rapidly detects when the user is eating a meal may offer a route towards fully closed-loop insulin delivery, shows a small crossover trial in adolescents and young adults.
A consensus statement covering the practical, ethical, and legal aspects of the use of open-source closed-loop insulin delivery algorithms is soon to be published, the authors reported at the virtual ATTD 2021 conference.
Completing a brief, adaptive questionnaire prior to each consultation with healthcare providers can focus discussions toward the immediate priorities and concerns of people with diabetes, shows a feasibility study.
The results of two studies published in JAMA indicate that real-time continuous glucose monitoring benefits people with type 1 or type 2 diabetes on a range of insulin regimens and from a wide variety of backgrounds.
The risk for subclinical atherosclerosis among people at low risk for cardiovascular death increases with increasing glycated hemoglobin levels and is raised even at levels below the prediabetes threshold, research shows.